Essex Woodlands Management as of March 31, 2019
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| pSivida | 38.0 | $75M | 42M | 1.79 | |
| Axogen (AXGN) | 29.2 | $58M | 2.7M | 21.06 | |
| Revance Therapeutics (RVNC) | 26.7 | $53M | 3.3M | 15.76 | |
| MediciNova (MNOV) | 4.9 | $9.7M | 1.2M | 8.28 | |
| Endologix | 0.7 | $1.3M | 1.3M | 1.03 | |
| Catalyst Biosciences | 0.3 | $640k | 79k | 8.14 | |
| Acura Pharmaceuticals (ACUR) | 0.2 | $352k | 2.0M | 0.18 | |
| Corium Intl | 0.0 | $0 | 0 | 0.00 |
